Jefferies Rates Quantinuum (QNT) buy, $90 Price Target

Analyst Kevin Garrigan maintains a positive stance on Quantinuum Inc. as Wall Street evaluates the quantum computing firm's path forward, a 10.11% upside from the current price.

By TradeTexts Research Desk · Published Jul 1, 2026, 3:02 AM EDT · Updated Jul 1, 2026, 11:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Jefferies rated Quantinuum Inc. ($QNT) "buy" with a $90 price target on June 29, 2026.

Since the rating, $QNT is up 14.2% after 1 week, down 35.0% after 1 month and down 49.8% to date (from the $72.84 close on Jun 29, 2026).

QNT Quantinuum Inc.

$36.55 -35.33% past 3 months

Daily close · Oct 16, 2026

Key Points

Jefferies analyst Kevin Garrigan reaffirmed a buy rating on Quantinuum Inc. QNT on June 29, 2026, keeping a price target of $90.00.
Jefferies's $90 price target implies 10.11% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
The broader analyst community features a strong buy consensus across 12 opinions, backed by a mean price target of $97.17.
Quantinuum trades near $81.74 on the NasdaqGM, sitting well above its 52-week low of $46.54.

Get $QNT trade alerts by text

We text you when insiders, Congress or big funds trade $QNT. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Quantinuum Inc. alert may contain errors. Disclosures

Jefferies Maintains Buy Stance on Quantinuum Shares

Jefferies has reaffirmed its support for Quantinuum Inc. QNT, with analyst Kevin Garrigan keeping a buy rating and a $90.00 price target on June 29, 2026. This call places the firm right alongside other major financial institutions tracking the quantum computing provider. The update fits into a broader pattern of recent research notes from major houses evaluating the software and hardware developer's market position.

Analyst rating track record

Jefferies vs. the S&P 500

YTD return +49.31% hypothetical

All-time return +129.08% S&P 500 +28.13%

vs. S&P 500 +100.95% ahead of the index

Hypothetical returns from Jefferies's disclosed trades, not real profit or advice. How we model this.

12-month forecast

$QNT price target

Quantinuum Inc. daily closes and this analyst's $90 target. Not advice.

Wall Street Ratings and Recent Analyst Moves

Wall Street holds a strong buy consensus on Quantinuum across 12 analyst opinions, with a mean price target of $97.17. Price targets span from a low of $78.00 up to a high of $155.00. Other firms have actively adjusted their outlooks in recent months. On October 15, 2026, Morgan Stanley adjusted its view to an Overweight rating with a $62.00 target, down from a previous $78.00 target. Earlier on August 19, 2026, Rosenblatt maintained a buy rating with a $155.00 target. Bernstein also kept an Outperform rating with a $95.00 target on August 12, 2026, while Needham and Cantor Fitzgerald reaffirmed their respective buy and overweight ratings on the exact same day.

Stock Valuation and Price Action

Quantinuum shares change hands around $81.74 on the NasdaqGM. The stock has experienced a wide trading span over the past 52 weeks, falling as low as $46.54 while reaching a peak of $86.79. With a market capitalization near $2.01 billion, the company carries a forward P/E ratio that is not meaningful due to current net losses. Market participants continue to monitor price action as the equity trades well above both its 50-day moving average of $54.91 and its 200-day moving average of $59.15.

Inside Quantinuum's Software and Hardware Platform

Headquartered in Broomfield, Colorado, Quantinuum manufactures and develops quantum computing hardware and software. The company builds an integrated platform combining quantum systems, middleware, and application libraries designed for real-world deployment. Founded in 2021, the firm employs roughly 800 people to support its ongoing research and commercialization efforts in the technology sector.

What to Watch Next for QNT

Investors will be looking toward the company's next earnings report scheduled for November 9, 2026, for updates on revenue growth and software deployment. Analyst price targets and ratings remain subject to shifts as management provides further operational milestones. This report relies strictly on public disclosures and does not constitute financial advice.